Results 13,061-13,080 of 15,268 for speaker:Kathleen Lynch

Written Answers — Department of Health: Suicide Prevention (22 Sep 2015)

Kathleen Lynch: General Practice has long been identified as the most frequent first point of contact for people with suicidal thoughts, and international evidence highlights GP training in depression and the management of suicidal behaviour as critical to reducing suicide rates. In 2011, the Irish College of General Practitioners and the HSE’s National Office for Suicide Prevention (NOSP) partnered...

Written Answers — Department of Health: Suicide Prevention (22 Sep 2015)

Kathleen Lynch: I propose to take Questions Nos. 728, 729 and 738 together. The role of the National Office for Suicide Prevention (NOSP) is to oversee the implementation of the present suicide prevention strategy Connecting for Life, and to coordinate suicide prevention initiatives around the country. NOSP helps to support a wide array of work in communities, in partnership with the voluntary sector, across...

Written Answers — Department of Health: Medicinal Products Availability (22 Sep 2015)

Kathleen Lynch: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013, therefore, the matter has been referred to the HSE for attention and direct reply to you. If you have not received a reply from the...

Written Answers — Department of Health: Suicide Prevention (22 Sep 2015)

Kathleen Lynch: Suicide is a tragedy that we are constantly working to prevent and also working to give more support to the families affected. Dealing with the current high levels of suicide and deliberate self harm continues to be a priority for this Government. The HSE's National Office for Suicide Prevention (NOSP) has developed a range of initiatives designed to support people who are suicidal and also...

Written Answers — Department of Health: Mental Health Services Funding (22 Sep 2015)

Kathleen Lynch: I propose to take Questions Nos. 736, 799 and 842 together. As this is a service issue these questions have been referred to the HSE for direct reply. If you have not received a reply within 15 working days, please contact my Private Office and they will follow up the matter with them.

Written Answers — Department of Health: Suicide Bereavement Support (22 Sep 2015)

Kathleen Lynch: Bereavement support for families and communities is critically important in the aftermath of a death by suicide. The aim of bereavement support is to support those immediately affected by the death, to allow them to express their grief and to prevent more suicides from happening in the same area. A range of local and national services provide suicide bereavement support to families and...

Written Answers — Department of Health: Suicide Prevention (22 Sep 2015)

Kathleen Lynch: Funding for suicide prevention is primarily provided by the HSE’s National Office of Suicide Prevention. In addition, my Department has, in the past, provided relevant organisations with National Lottery funding for the years in question. Details of this are as follows: Year Organisation Purpose Grant Paid Waterford & South East Branch of Samaritans Renovating Premises...

Written Answers — Department of Health: Medical Card Applications (22 Sep 2015)

Kathleen Lynch: The Health Service Executive has been asked to examine this matter and to reply to the Deputy as soon as possible. The Health Service Executive operates the General Medical Services scheme, which includes medical cards and GP visit cards, under the Health Act 1970, as amended. It has established a dedicated contact service for members of the Oireachtas specifically for queries relating to...

Written Answers — Department of Health: Medical Aids and Appliances Applications (22 Sep 2015)

Kathleen Lynch: As this is a service matter, it has been referred to the Health Service Executive (HSE) for attention and direct reply. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.

Written Answers — Department of Health: Medicinal Products Availability (22 Sep 2015)

Kathleen Lynch: I propose to take Questions Nos. 745, 749, 815, 820, 994 and 1088 together. The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013. Prior to reimbursing any medicine, the HSE considers a range of statutory criteria,...

Written Answers — Department of Health: Respite Care Services (22 Sep 2015)

Kathleen Lynch: As this is a service matter it has been referred to the Health Service Executive for direct reply. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.

Written Answers — Department of Health: Respite Care Services (22 Sep 2015)

Kathleen Lynch: I propose to take Questions Nos. 751 and 901 together. As these are service matters they have been referred to the Health Service Executive for direct reply. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.

Written Answers — Department of Health: Hospitals Discharges (22 Sep 2015)

Kathleen Lynch: Delayed discharges arise when a patient has been judged clinically to no longer have a requirement for acute hospital care but remains in an acute hospital bed, thus rendering that bed unavailable for patients who need admission. As of 15 September (latest figures available) there are 586 delayed discharges nationally, of which 308 are in the Dublin Academic Teaching Hospitals. Delayed...

Written Answers — Department of Health: Medicinal Products Availability (22 Sep 2015)

Kathleen Lynch: I propose to take Questions Nos. 755 and 782 together. The Health Service Executive (HSE) has statutory responsibility for decisions on the pricing and reimbursement of medicinal products under the GMS and community drugs schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013. I am happy to inform you that the HSE has decided to reimburse the...

Written Answers — Department of Health: Medicinal Products Licensing (22 Sep 2015)

Kathleen Lynch: I propose to take Questions Nos. 757, 758, 765 and 768 together. The Health Products Regulatory Authority’s (HPRA) regulatory role (and that of other medicines agencies) involves the technical assessment of safety data from various sources of post-marketing experience, including further studies, literature reviews, and evaluation of adverse reaction data. The HPRA liaises on a...

Written Answers — Department of Health: Medicinal Products Availability (22 Sep 2015)

Kathleen Lynch: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013, therefore, the matter has been referred to the HSE for attention and direct reply to you If you have not received a reply from the...

Written Answers — Department of Health: Clinical Trials (22 Sep 2015)

Kathleen Lynch: Roaccutane® is the brand name for the medicinal substance isotretinoin which is authorised for use in the treatment of severe forms of acne. In the application for a marketing authorisation for Roaccutane®, received by the then Irish Medicines Board (now the Health Products Regulatory Authority) in 1982, 451 subjects entered clinical trials of isotretinoin (Roaccutane®) for...

Written Answers — Department of Health: Magdalen Laundries (22 Sep 2015)

Kathleen Lynch: The Government accepted all the recommendations of the Quirke report and established an ex gratiarestorative justice scheme. Under the scheme, the Government then set up a range of payments of up to €100,000 along with supports, for the women who worked in these institutions. In his report, Mr Justice Quirke recommended, inter alia, that legislation be introduced to give effect to...

Written Answers — Department of Health: Medical Products (22 Sep 2015)

Kathleen Lynch: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013. Prior to reimbursing any medicine, the HSE considers a range of statutory criteria, including clinical need, cost-effectiveness and the...

Written Answers — Department of Health: HSE Complaints Procedures (22 Sep 2015)

Kathleen Lynch: The Health Service Executive (HSE) has a Complaints Policy "Your Service, Your Say", which includes a number of options available for people, including people with disabilities, to provide feedback or make complaints. These include making the complaint in person; via an on-line feedback form; by e-mail; by letter; by telephone call; through the Confidential Recipient for Vulnerable Persons...